Oral Fluoropyrimidines in the Treatment of Advanced Colorectal Cancer: Results of Two Consecutive Phase II Trials

Authors

  • Parvin Adimi From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark
  • Flemming Hansen From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark
  • Mogens Kjaer From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark
  • Kristian Aabo From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark
  • Nina Keldsen From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark
  • Per Pfeiffer From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark
  • Erik Sandberg From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark
  • Anders Jakobsen From the Departments of Oncology, Vejle Hospital (P. Adimi, A. Jakobsen), Aarhus University Hospital (F. Hansen), Aalborg Hospital (M. Kjaer), Herning Central Hospital (N. Keldsen), Odense University Hospital (P. Pfeiffer) and Esbjerg Hospital (E. Sandberg), and the Department of Medicine, Viborg Hospital (K. Aabo), Denmark

DOI:

https://doi.org/10.1080/028418602753669625

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

2002-01-01

How to Cite

Adimi, P., Hansen, F., Kjaer, M., Aabo, K., Keldsen, N., Pfeiffer, P., … Jakobsen, A. (2002). Oral Fluoropyrimidines in the Treatment of Advanced Colorectal Cancer: Results of Two Consecutive Phase II Trials. Acta Oncologica, 41(2), 202–203. https://doi.org/10.1080/028418602753669625

Issue

Vol. 41 No. 2 (2002): Acta Oncologica

Section

Articles